Related Experiment Video
Updated: Aug 6, 2026
05:19
Practical Methodology of Cognitive Tasks Within a Navigational Assessment
Published on: June 1, 2015
Navigating cognitive challenges: assistive solutions for Parkinson's (a narrative review)
1Physiotherapy Program, Vocational School, Istanbul Medipol University, Istanbul, Turkey.
Assistive Technology : the Official Journal of RESNA
|July 17, 2026
Summary
Assistive technologies show promise in improving cognitive functions like memory and attention for individuals with Parkinson's disease (PD). Further research is needed to determine the most effective technologies for PD rehabilitation.
Area of Science:
- Neuroscience
- Rehabilitation Technology
- Clinical Trials
Background:
- Parkinson's disease (PD) presents with motor and cognitive impairments.
- Assistive technologies (ATs) are increasingly used for PD, but their cognitive impact is unclear.
Purpose of the Study:
- To review randomized controlled trials (RCTs) on the impact of ATs on cognitive function in Parkinson's disease.
- To synthesize findings on the effectiveness of various ATs in PD rehabilitation.
Main Methods:
- Systematic review of RCTs published 2018-2024 from PubMed, PEDro, Scopus.
- Inclusion of 7 trials with interventions like apps, VR, and robotics.
- Assessment of cognitive function using validated scales and trial quality via PEDro scale.
Main Results:
- Assistive technologies positively impacted memory, attention, executive function, and mood in PD patients.
- Improvements were observed alongside motor function and quality of life enhancements.
- Interventions varied from 15-24 sessions using diverse technologies.
Conclusions:
- Assistive technologies offer potential benefits for cognitive function in Parkinson's disease.
- Further research is required to identify optimal ATs and application strategies for PD rehabilitation.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...